Overview
Scapuloperoneal spinal muscular atrophy (SPMA) is a rare subtype of spinal muscular atrophy characterized by progressive muscle weakness predominantly affecting the shoulder girdles and lower extremities, often with sparing of the proximal upper limbs 1.Diagnosis
Clinical presentation includes progressive muscle weakness in the scapular and peroneal regions 1.
Electromyography (EMG) and muscle biopsy may confirm denervation and atrophy 1.
Genetic testing for mutations in the SMN1 gene is essential for diagnosis 1.
Cardiac evaluation, including ECG and echocardiography, is recommended due to potential conduction abnormalities 1.Management
No specific curative treatment exists; management focuses on supportive care 1.
Physical therapy to maintain joint mobility and prevent contractures 1.
Respiratory support may be necessary in advanced stages 1.
Cardiac monitoring is crucial, especially for conduction abnormalities 1.Special Populations
Cardiac Considerations: Patients may develop complete heart block; regular cardiac evaluations are advised 1.
Comorbidities: No specific pediatric, elderly, or pregnancy-related management differences noted in the provided abstracts 1.Key Recommendations
Conduct regular cardiac evaluations including ECG and echocardiography to monitor for conduction abnormalities in SPMA patients (Evidence: Weak) 1.
Implement supportive physical therapy to manage muscle weakness and prevent complications like contractures (Evidence: Expert opinion) 1.
Provide respiratory support as needed based on disease progression and functional status (Evidence: Expert opinion) 1.References
1 Ponder BA, Chatterjee K, Sutton GC. Complete heart block in patients with peroneal muscular atrophy. Postgraduate medical journal 1971. link